How taxpayers prop up Big Pharma, and how to cap that

By Mariana Mazzucato

When Martin Shkreli of Turing Pharmaceuticals raised the price for Daraprim by 5,455%, he put drug pricing on the agenda for the leading 2016 presidential candidates. Bernie Sanders is reported to have rejected Shkreli’s campaign donation, and Hillary Rodham Clinton came out with a plan to tackle spiraling costs. Even Donald Trump called Shkreli a spoiled brat.”…

[Click HERE to read the full article]

Back to top button
Close